Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.73% |
| 2 | Technology | 20.55% |
| 3 | Financials | 7.82% |
| 4 | Consumer Discretionary | 7.64% |
| 5 | Communication Services | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4951
Envela
ELA
$313M
| $14.6K | ﹤0.01% |
2,383
+1,886
| +379% | +$11.7K |
2023 Q1
9 quarters
|
|
4952
DELISTED
Leslie's
LESL
| $14.6K | ﹤0.01% |
1,736
-5,256
| -75% | -$69.2K |
2020 Q4
18 quarters
|
|
4953
Uxin Ltd
UXIN
$222M
| $14.4K | ﹤0.01% |
3,900
| – | – |
2025 Q1
1 quarter
|
|
4954
Comp X International
CIX
$444M
| $14.3K | ﹤0.01% |
538
-538
| -50% | -$13.3K |
2016 Q1
37 quarters
|
|
4955
PUT
Carnival Corporation Ltd
CCL
$34.8B
| $14.1K | ﹤0.01% |
500
-350,000
| -100% | -$7.49M |
2022 Q3
11 quarters
|
|
4956
Neumora Therapeutics
NMRA
$89M
| $14K | ﹤0.01% |
19,126
-46,721
| -71% | -$35.4K |
2023 Q3
7 quarters
|
|
4957
CALL
Lifezone Metals Ltd Warrants
LZM.WS
$26.1M
| $13.8K | ﹤0.01% |
45,000
| – | – |
2023 Q3
7 quarters
|
|
4958
Nuveen ESG Mid-Cap Value ETF
NUMV
$446M
| $13.7K | ﹤0.01% |
380
| – | – |
2022 Q1
13 quarters
|
|
4959
Valhi
VHI
$416M
| $13.6K | ﹤0.01% |
844
-861
| -50% | -$13.8K |
2013 Q2
48 quarters
|
|
4960
Main Street Capital
MAIN
$5.03B
| $13.5K | ﹤0.01% |
+229
| New | +$12.7K |
2025 Q2
0 quarters
|
|
4961
DNA X Inc
SONM
$4.87M
| $13.5K | ﹤0.01% |
+613
| New | +$15.1K |
2025 Q2
0 quarters
|
|
4962
iShares ESG MSCI EM Leaders ETF
LDEM
$32.1M
| $13.4K | ﹤0.01% |
249
+152
| +157% | +$7.64K |
2025 Q1
1 quarter
|
|
4963
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$781M
| $13.2K | ﹤0.01% |
328
| – | – |
2015 Q2
40 quarters
|
|
4964
RLX Technology
RLX
$2.08B
| $13K | ﹤0.01% |
+5,870
| New | +$11.5K |
2025 Q2
0 quarters
|
|
4965
iShares MSCI United Kingdom Small-Cap ETF
EWUS
$39.5M
| $12.9K | ﹤0.01% |
310
| – | – |
2021 Q2
16 quarters
|
|
4966
Invesco Biotechnology & Genome ETF
PBE
$418M
| $12.8K | ﹤0.01% |
200
| – | – |
2013 Q2
48 quarters
|
|
4967
Actuate Therapeutics
ACTU
$14.5M
| $12.8K | ﹤0.01% |
2,089
+1,440
| +222% | +$12.6K |
2024 Q3
3 quarters
|
|
4968
DELISTED
Soho House & Co
SHCO
| $12.7K | ﹤0.01% |
1,731
-155
| -8% | -$962 |
2024 Q4
2 quarters
|
|
4969
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$253M
| $12.7K | ﹤0.01% |
200
-173,521
| -100% | -$10.3M |
2013 Q2
48 quarters
|
|
4970
iShares 0-3 Month Treasury Bond ETF
SGOV
$115B
| $12.7K | ﹤0.01% |
126
+92
| +271% | +$9.25K |
2023 Q4
6 quarters
|
|
4971
Immatics
IMTX
$1.02B
| $12.5K | ﹤0.01% |
2,321
+563
| +32% | +$2.79K |
2023 Q2
8 quarters
|
|
4972
Quantum Corp
QMCO
$728M
| $12.3K | ﹤0.01% |
+1,236
| New | +$13.7K |
2025 Q2
0 quarters
|
|
4973
Nano Dimension
NNDM
$594M
| $12.3K | ﹤0.01% |
7,599
-89
| -1% | -$136 |
2020 Q4
18 quarters
|
|
4974
First Trust Emerging Markets AlphaDEX Fund
FEM
$792M
| $12.3K | ﹤0.01% |
500
| – | – |
2013 Q4
46 quarters
|
|
4975
LanzaTech
LNZA
$60.5M
| $12.2K | ﹤0.01% |
451
-357
| -44% | -$8.76K |
2023 Q1
9 quarters
|
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2025 filing shows 467 new, 1,653 increased, 2,974 reduced and 377 closed positions. Its largest new stake was Amrize Ltd: 2,294,135 shares worth $114M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $625M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 467 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.